Insider · CIK 0001305178
Jill Marie Broadfoot
Files at ATYR (aTYR PHARMA INC), CUE (Cue Biopharma, Inc.). First filing Feb 4, 2025, latest Feb 4, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ATYR: aTYR PHARMA INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2025 | CUE Cue Biopharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +48,800 | $0.00 | $0 | 48,800 | Jun 6, 2025 |
| Feb 3, 2025 | ATYR aTYR PHARMA INC | MOption exercise Common Stock | +3,750 | - | - | 33,017 | Feb 4, 2025 |
| Feb 4, 2025 | ATYR aTYR PHARMA INC | SOpen-market sale Common Stock | -1,254 | $3.78 | $4,740 | 31,763 | Feb 4, 2025 |
| Feb 3, 2025 | ATYR aTYR PHARMA INC | MOption exercise Restricted Stock Unitderivative | -3,750 | $0.00 | $0 | 3,750 | Feb 4, 2025 |
| Jan 8, 2025 | ATYR aTYR PHARMA INC | AGrant or award Employee Stock Option (right to buy)derivative | +275,000 | $0.00 | $0 | 275,000 | Jan 10, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.